Granulocyte colony-stimulating factor (G-CSF) production by astrocytoma cells and its effect on tumor growth

Journal of Neuro-Oncology

Volumn 27, Issue 1, 1996, Pages 31-38

  Kikuchi, Tetsuro ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ELISA; Glioma; Granulocyte colony stimulating factor; RT PCR

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; MESSENGER RNA; RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOMA CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYST FLUID; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOKINE ACTIVATED KILLER CELL; MALE; MOUSE; NONHUMAN; SCHOOL CHILD; TUMOR GROWTH;

ADULT; AGED; ANIMALS; ASTROCYTOMA; BASE SEQUENCE; BODY FLUIDS; CELL DIVISION; CELL SURVIVAL; CHILD; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; KILLER CELLS, LYMPHOKINE-ACTIVATED; MALE; MICE; MICE, INBRED STRAINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RECOMBINANT PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030042651     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00146081     Document Type: Article

References (23)

1. Brandes A, Soesan M, Florentino M: Medical treatment of high grade malignant gliomas in adults: an overview. Anticancer Res 11: 1988-1992, 1991
2. Barba D, Saris S, Holder C, Rosenberg S, Oldfield E: Intratumoral LAK cell and interleukin-2 therapy of human gliomas. J Neurosurg 70: 175-182, 1989
3. Blick M, Sherwin S, Rosenblum M, Gutterman J: Phase 1 study of recombinant tumor necrosis factor in cancer patients. Cancer Res 47: 2986-2989, 1987
4. Mac Manus M, Clarke J, Abram W: Use of G-CSF to treat neutropenia occurring during craniospinal irradiation in children with brain tumors. Br J Cancer 66: 27, 1992
5. Morstyn G, Burgess A: Hemopoietic growth factors: a review. Cancer Res 48: 5624-5637, 1988
6. Bodmer S, Strommer K, Frei K, Sieple C, de Tribolet N, Heid I, Fontana A: Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. J Immunol 143: 3222-3229, 1989
7. Gauthier T, Hamou M, Monod L, Gallay P, Carrel S, de Tribolet N: Expression and release of interleukin-1-alpha and beta by human glioblastoma cells in vitro and in vivo. Acta Neurochir 121: 199-205, 1993
8. Van Meir E, Sawamura Y, Diserens A, Hamou M, de Tribolet N: Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res 50: 6683-6688, 1990
9. Frei K, Mlipieiro U, Piani D, Van Meir E, de Tribolet N, Fontana A: GM-CSF production by glioblastoma cells: despite the presence of inducing signals GM-CSF is not expressed in vivo. J Immunol 148: 3140-3146, 1992
10. Van Meir E, Ceska M, Effenberger F, Walz A, Grouzmann E, Desbaillets I, Frei K, Fontana A, de Tribolet N: Interleukin-8 produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 53: 4297-4305, 1992
11. Tweardy D J, Mott PL, Glazer EW: Monokine modulation of human astroglial cell production of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. J Immunol 144: 2233-2241, 1990
12. Nicola N, Metcalf D, Matsumoto M, Johnson C: Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells: identification as granulocyte colony stimulating factor. J Biol Chem 158: 9017-9023, 1983
13. Shameem I, Kurisu H, Matsuyama H, Shimabukuro T, Naito K: Direct and indirect effects of recombinant human granu-locyte-colony stimulating factor on in vitro colony formation of human bladder cancer cells. Cancer Immunol Immunother 38: 353-357, 1994
14. Sakamoto K, Hoshino H, Kiuchi Y, Nakano G, Nagamachi Y: Potential use fullness of a cultured glioma cell line induced by rous sarcoma virus in B10.A mouse as an immunotherapy model. Jpn J Exp Med 59: 173-180, 1989
15. Mise T, Kuwai T, Watanabe M: A high sensitivity immunoassay (ELISA) and receptor binding assay for human G-CSF. Biotherapy 7: 1627-1633, 1993
16. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxity assays. J Immunol Methods 65: 55-63, 1983
17. Kikuchi T, Watanabe M, Ohno T: Cytological characteristics of human glioma-infiltrating lymphocytes stimulated with recombinant interleukin-2 and an anti-CD3 antibody. Jpn J Cancer Res 82: 339-345, 199118.
18. Stan A, Walter G, Weite K, Pietsch T: Immunolocalization of granulocyte-colony stimulating factor in human glial and primitive neuroectodermal tumors. Int J Cancer 57: 306-312, 1994
19. Segawa K, Ueno Y, Kataoka T: In vivo tumor growth enhancement by granulocyte colony-stimulating factor. Jpn J Cancer Res 82: 440-447, 1991
20. Dedhar S, Gaboury L, Galloway P, Eaves C: Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin. Proc Natl Acad Sci USA 85: 9253-9257, 1988
21. Baldwin G, Gasson J, Kaufman S, Quan S, Williams R, Avalos B: Nonhemotopoietic tumor cells express functional GM-CSF receptors. Blood 73: 1033-1037, 1989
22. Weitzman SA, Weitberg AB, Clark EP, T.P. S: Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science 227: 1231-1233, 1985
23. Brooks W, Netzky M, Normansell D, Horwitz D: Depressed cell mediated immunity in patients with primary intracranial tumors. J Exp Med 136: 1631-1647, 1972